To whom XCLARIS is addressed

XCLARIS BRCA Panel is particularly indicated in:

  • Familiarity for breast, ovarian, pancreatic or prostate cancer in three or more cases in the same family branch
  • Patients with non-mucinous and non-borderline ovarian carcinoma, fallopian tube carcinoma or primary peritoneal carcinoma
  • Woman with breast cancer before the age of 36
  • Woman with breast cancer and ovarian cancer
  • Woman with triple negative breast cancer under the age of 60
  • Woman with bilateral breast cancer less than 50 years old
  • Male breast cancer
  • Patients with metastatic pancreatic cancer